Study Stopped
Change in design to observational study
Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit
SDPPNCU
1 other identifier
interventional
1
1 country
1
Brief Summary
The role of sleep in patients admitted to the intensive care unit is an emerging field of research. There have been studies that show patients in the ICU have poor sleep including sleep fragmentation, multiple arousals, decreased stage 3 sleep and reduced REM sleep (1, 2, 3). Causes of poor sleep in the ICU include severity of illness, abnormal light exposure, and frequent arousals for medical care. Not only does poor sleep contribute to reduced cognitive function and delirium, but there are also implications for the immune system function and wound healing (4). Polysomnography is regarded as the gold standard for sleep studies, however it has limited utility in the ICU population (5) and alternative methods of sleep analysis need to be investigated to better understand the underlying physiologic mechanisms and subsequent cognitive effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 16, 2016
CompletedFirst Posted
Study publicly available on registry
December 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2018
CompletedApril 3, 2018
April 1, 2018
1.3 years
December 16, 2016
April 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Detect the effects of disrupted sleep with quantitative EEG analysis
The investigators will use an automated EEG detection system used in patients with continuous EEG (cEEG) monitoring to detect duration of sleep related EEG brain activity, number of intervals of activation, and the duration of the intervals for sleep activities including: REM, Stage 1, stage 2, and stage 3 sleep, sleep spindles, and alpha activity.
Up to 12 hours
Secondary Outcomes (3)
Precision, accuracy and bias of the automated cEEG algorithm by comparing it to the interpretations of sleep trained neurologists
Up to 4 hours
Subjective measure of sleep assessment using the Richards-Campbell Sleep Questionnaire
Up to 12 hours
Quantitative assessment of alertness using a psychomotor vigilance task (PVT).
Up to 12 hours
Study Arms (2)
group 2
NO INTERVENTIONno intervention
group 1
OTHERsleep disruption
Interventions
Group two will have interrupted sleep at time periods of 2 hours post operatively. Group two will be woken every 2 hours, which is the standard NCCU protocol.
Eligibility Criteria
You may qualify if:
- post operative back patients in the NCCU with no history of brain injury
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins
Baltimore, Maryland, 21287, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul A Nyquist, MD
Johns Hopkins school of medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2016
First Posted
December 20, 2016
Study Start
December 1, 2016
Primary Completion
March 26, 2018
Study Completion
March 26, 2018
Last Updated
April 3, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share